How Gorgas was paid
$1.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Gregory D. GorgasPresident, CEO, Secretary, and Director and Former CFO and Treasurer | $540,000 | $270,000 | — | $346,532 | $66,923 | $1,223,455 |
| Mark E. SpringCFO and Treasurer | $41,667 | — | $64,555 | — | $184,313 | $290,535 |
What changed and why
- $1.2M$1,223,455: CEO total compensation in 2025, compared with $1,060,470 in 2024.
- $347K$346,532: CEO option awards in 2025, compared with $240,016 in 2024.
- $184K$184,313: Mark Spring’s consulting fees, included in all other compensation.
- 50%50%: CEO annual target bonus opportunity as a percentage of base salary.
- $20,000$20,000: CEO retention stock option approved in July 2025.
- 24 months: New standard cash severance and COBRA reimbursement period for the CEO outside a change in control.
Other Artelo Biosciences proxy statements
- 2025 proxy statement
Gregory D. Gorgas paid $1.1M (+7% on the year).
Filed Dec 11, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.